Dr. Zacks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Wall St
Ann Arbor, MI 48105Phone+1 734-764-4190
Summary
- Dr. David Zacks is a retina specialist who sees patients at the University of Michigan Kellogg Eye Center's office in Ann Arbor. His clinical interests include diseases and surgery of the retina and vitreous, including retinal detachments, diabetic retinopathy, age-related macular degeneration, retinal vascular disease, ocular trauma, ocular inflammation, and macular and submacular surgery.
Dr. Zacks' research focuses on the mechanisms of retinal cell death during retinal diseases such as retinal detachments, age-related macular degeneration, and ocular inflammatory disease. His particular focus is on the role of apoptosis in the death of photoreceptor cells and the development of neuroprotective therapies for preservation of retinal elements during retinal disease.
To make an appointment, please call the Kellogg Eye Center Retina and Uveitis Clinic in Ann Arbor at 734-763-5874. To refer a patient, please visit www.kellogg.umich.edu/refer.
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Surgical Retina and Vitreous, 2000 - 2002
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1997 - 2000
- Brigham and Women's Faulkner HospitalInternship, Department of Medicine, 1996 - 1997
- Albert Einstein College of MedicineClass of 1996
- Cornell UniversityBS, Neurobiology and Behavior, 1984 - 1988
Certifications & Licensure
- MI State Medical License 2002 - 2027
- MA State Medical License 2000 - 2004
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO) Start of enrollment: 2020 Feb 25
Publications & Presentations
PubMed
- 1678 citationsGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition)Daniel J. Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, Mahmoud Abdellatif, Asghar Abdoli
Autophagy. 2021-02-08 - 61 citationsAdvancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano SymposiumDebra A. Thompson, Alessandro Iannaccone, Robin R. Ali, Vadim Y. Arshavsky, Isabelle Audo
Translational Vision Science & Technology. 2020-06-03 - 71 citationsAutophagy activation in the injured photoreceptor inhibits fas-mediated apoptosis.Cagri G. Besirli, Nicholas D. Chinskey, Qiong Duan Zheng, David N. Zacks
Investigative Ophthalmology & Visual Science. 2011-06-13
Journal Articles
- Vitreous Cytokine Expression and a Murine Model Suggest a Key Role of Microglia in the Inflammatory Response to Retinal DetachmentLee Kiang, David N Zacks, Cagri G Besirli, Investigative Ophthalmology and Visual Science
Press Mentions
- Conducting Impactful Research as a Retina FellowMarch 2nd, 2023
- BitLicense at 5: For Startups Regulated Overseas, New York Isn’t so ToughJune 24th, 2020
- SUBSPECIALTY NEWS: Subspecialty News Slowing Geographic Atrophy Progression, Studying Retinal Detachment, Developing Treatment for Macular Edema Due to Uveitis, and MoreJanuary 1st, 2020
- Join now to see all
Grant Support
- Autophagy And Control Of Photoreceptor ApoptosisNational Eye Institute2010–2011
- Apoptosis In Retinal DetachmentsNational Eye Institute2002–2006
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: